Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A

Journal Article · · Journal of Medicinal Chemistry

Research Organization:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Organization:
~OTHER
DOE Contract Number:
SC0012704
OSTI ID:
1690191
Report Number(s):
BNL-220512-2020-JACI
Journal Information:
Journal of Medicinal Chemistry, Vol. 63, Issue 19
Country of Publication:
United States
Language:
English

References (76)

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management February 2001
Recent developments in clinical trials of botulinum neurotoxins June 2018
Botulinum toxin in clinical practice July 2004
Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum Toxin January 2015
The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly Poison October 2008
The janus faces of botulinum neurotoxin: Sensational medicine and deadly biological weapon January 2007
Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk June 2005
Wound Botulism Associated With Black Tar Heroin Among Injecting Drug Users March 1998
Is black tar heroin use associated with wound botulism? A report of two Hispanic patients May 2018
Wound Botulism Outbreak Among Persons Who Use Black Tar Heroin — San Diego County, California, 2017–2018 January 2019
Translocation of botulinum neurotoxin light chain protease through the heavy chain channel December 2002
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 September 1993
Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses February 1999
Equine antitoxin use and other factors that predict outcome in type A foodborne botulism May 1984
The life history of a botulinum toxin molecule June 2013
The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes March 2018
Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells February 2014
Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6 October 2018
Strategies to Counteract Botulinum Neurotoxin A: Nature’s Deadliest Biomolecule July 2019
Targeting Metalloenzymes for Therapeutic Intervention September 2018
Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification Chemistry April 2006
Synthesis and structure–activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors December 2007
Chirality Holds the Key for Potent Inhibition of the Botulinum Neurotoxin Serotype A Protease January 2010
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain February 2014
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain Complexed with Small-Molecule Inhibitors Highlight Active-Site Flexibility May 2007
Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies March 2013
Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model January 2006
Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions June 2010
Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite June 2012
Mechanism-based Inhibition of Metalloproteinases January 2004
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A’s zinc endopeptidase January 2010
Novel benzimidazole inhibitors of botulinum neurotoxin/A display enzyme and cell-based potency January 2011
Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors December 2011
Benzoquinones as inhibitors of botulinum neurotoxin serotype A August 2014
Covalent Modifiers of Botulinum Neurotoxin Counteract Toxin Persistence December 2018
High-Throughput Multiplex Flow Cytometry Screening for Botulinum Neurotoxin Type A Light Chain Protease Inhibitors February 2010
Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases April 2016
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors April 2020
Structural Analysis of Botulinum Neurotoxin Type E Catalytic Domain and Its Mutant Glu212→Gln Reveals the Pivotal Role of the Glu212 Carboxylate in the Catalytic Pathway , June 2004
Structural Analysis of Botulinum Neurotoxin Serotype F Light Chain:  Implications on Substrate Binding and Inhibitor Design August 2005
Structural and Biochemical Studies of Botulinum Neurotoxin Serotype C1 Light Chain Protease:  Implications for Dual Substrate Specificity , August 2007
Crystal Structure of Botulinum Neurotoxin Type G Light Chain:  Serotype Divergence in Substrate Recognition , June 2005
Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity March 2018
Structure of Botulinum Neurotoxin Type D Light Chain at 1.65 Å Resolution:  Repercussions for VAMP-2 Substrate Specificity , February 2006
Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain January 2014
Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin A: Effects of zinc ion and peptides on inhibition November 2009
Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning March 1997
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays January 2017
New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model February 2018
Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrations January 2008
Aryl Vinyl Sulfonates and Sulfones as Active Site-Directed and Mechanism-Based Probes for Protein Tyrosine Phosphatases June 2008
Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase March 2000
The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K January 2019
A comparative study of warheads for design of cysteine protease inhibitors November 2017
Development of a Fluorescence Internal Quenching Correction Factor to Correct Botulinum Neurotoxin Type A Endopeptidase Kinetics Using SNAPtide December 2012
Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A Inhibitors May 2006
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists February 2007
Antitoxin Levels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and E September 1984
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring June 2014
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases June 2007
To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition January 2010
Zinc-Binding Groups Modulate Selective Inhibition of MMPs May 2008
Metal Ions Effectively Ablate the Action of Botulinum Neurotoxin A May 2017
The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability September 2004
Catalytic Features of the Botulinum Neurotoxin A Light Chain Revealed by High Resolution Structure of an Inhibitory Peptide Complex May 2008
[20] Processing of X-ray diffraction data collected in oscillation mode January 1997
Phaser crystallographic software July 2007
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard December 2007
Coot model-building tools for molecular graphics November 2004
Polder maps: improving OMIT maps by excluding bulk solvent February 2017
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins December 2015
The Protein Data Bank January 2000
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments March 2013
A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies September 2007
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays December 1983
An Aggregation Advisor for Ligand Discovery August 2015